Cargando…
Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128369/ http://dx.doi.org/10.1016/j.jcv.2016.08.096 |
_version_ | 1783516549704843264 |
---|---|
author | Plachot, C. Huang, C. Vemula, R. Wu, J. Lee, H.J. Anekella, B. |
author_facet | Plachot, C. Huang, C. Vemula, R. Wu, J. Lee, H.J. Anekella, B. |
author_sort | Plachot, C. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7128369 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71283692020-04-08 Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika Plachot, C. Huang, C. Vemula, R. Wu, J. Lee, H.J. Anekella, B. J Clin Virol Article Published by Elsevier B.V. 2016-09 2016-09-12 /pmc/articles/PMC7128369/ http://dx.doi.org/10.1016/j.jcv.2016.08.096 Text en Copyright © 2016 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Plachot, C. Huang, C. Vemula, R. Wu, J. Lee, H.J. Anekella, B. Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika |
title | Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika |
title_full | Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika |
title_fullStr | Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika |
title_full_unstemmed | Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika |
title_short | Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika |
title_sort | use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as ebola, chikungunya, dengue-2, norovirus gii, mers-cov and zika |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128369/ http://dx.doi.org/10.1016/j.jcv.2016.08.096 |
work_keys_str_mv | AT plachotc useofrecombinantvirustechnologytoproducenoninfectiouswholeprocesscontrolsforemergingvirusessuchasebolachikungunyadengue2norovirusgiimerscovandzika AT huangc useofrecombinantvirustechnologytoproducenoninfectiouswholeprocesscontrolsforemergingvirusessuchasebolachikungunyadengue2norovirusgiimerscovandzika AT vemular useofrecombinantvirustechnologytoproducenoninfectiouswholeprocesscontrolsforemergingvirusessuchasebolachikungunyadengue2norovirusgiimerscovandzika AT wuj useofrecombinantvirustechnologytoproducenoninfectiouswholeprocesscontrolsforemergingvirusessuchasebolachikungunyadengue2norovirusgiimerscovandzika AT leehj useofrecombinantvirustechnologytoproducenoninfectiouswholeprocesscontrolsforemergingvirusessuchasebolachikungunyadengue2norovirusgiimerscovandzika AT anekellab useofrecombinantvirustechnologytoproducenoninfectiouswholeprocesscontrolsforemergingvirusessuchasebolachikungunyadengue2norovirusgiimerscovandzika |